RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+34.16%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$913M
AUM Growth
+$913M
(+14%)
Cap. Flow
-$73.3M
Cap. Flow
% of AUM
-8.04%
Top 10 Holdings %
Top 10 Hldgs %
28.56%
Holding
108
New
15
Increased
30
Reduced
36
Closed
14
Top Buys
| 1 |
Guardant Health
GH
|
$9.4M |
| 2 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$9.14M |
| 3 |
Intuitive Surgical
ISRG
|
$7.09M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$6.81M |
| 5 |
Cooper Companies
COO
|
$6.43M |
Top Sells
| 1 |
CVS Health
CVS
|
$12.1M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$12M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$11.5M |
| 4 |
Thermo Fisher Scientific
TMO
|
$11.1M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$9.05M |
Sector Composition
| 1 | Healthcare | 93.54% |
| 2 | Financials | 0.09% |
| 3 | Energy | 0.09% |
| 4 | Technology | 0.09% |
| 5 | Communication Services | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRAY
76
DELISTED
ViewRay, Inc.
VRAY
| $3.17M | 0.35% |
750,000
+114,566
| +18% | +$483K |
|
77
Regenxbio
RGNX
$498M
| $3.07M | 0.34% |
+75,000
| New | +$3.07M |
|
|
CLLS
78
Cellectis
CLLS
$260M
| $2.48M | 0.27% |
+144,604
| New | +$2.48M |
|
79
Apellis Pharmaceuticals
APLS
$3.51B
| $2.45M | 0.27% |
+80,000
| New | +$2.45M |
|
80
Viking Therapeutics
VKTX
$3.02B
| $1.6M | 0.18% |
200,000
| – | – |
|
|
PVLA
81
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
| $1.09M | 0.12% |
300,000
| – | – |
|
82
Chevron
CVX
$318B
| $358K | 0.04% |
2,974
| – | – |
|
83
Walt Disney
DIS
$211B
| $301K | 0.03% |
2,083
| – | – |
|
84
Qualcomm
QCOM
$170B
| $299K | 0.03% |
3,391
| – | – |
|
85
IBM
IBM
$227B
| $297K | 0.03% |
2,215
| – | – |
|
86
JPMorgan Chase
JPM
$824B
| $292K | 0.03% |
2,095
-377
| -15% | -$52.5K |
|
87
Wells Fargo
WFC
$258B
| $284K | 0.03% |
5,272
| – | – |
|
88
Ford
F
$46.2B
| $271K | 0.03% |
29,164
| – | – |
|
89
Exxon Mobil
XOM
$477B
| $269K | 0.03% |
3,854
| – | – |
|
90
Janus Henderson
JHG
$6.86B
| $260K | 0.03% |
10,645
| – | – |
|
91
AB InBev
BUD
$116B
| $230K | 0.03% |
2,806
-603
| -18% | -$49.4K |
|
92
Gen Digital
GEN
$18.3B
| $224K | 0.02% |
8,761
| – | – |
|
93
Alphabet (Google) Class A
GOOGL
$2.79T
| $214K | 0.02% |
+160
| New | +$214K |
|
94
Halliburton
HAL
$18.4B
| $203K | 0.02% |
+8,299
| New | +$203K |
|
|
MDCO
95
DELISTED
Medicines Co
MDCO
| – | – |
-153,000
| Closed | -$7.65M |
|
|
ARQL
96
DELISTED
Arqule Inc
ARQL
| – | – |
-200,000
| Closed | -$1.43M |
|
|
ACHN
97
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| – | – |
-277,800
| Closed | -$1M |
|
|
DPLO
98
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| – | – |
-1,060,000
| Closed | -$5.19M |
|
|
RARX
99
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| – | – |
-244,000
| Closed | -$5.77M |
|
|
HMSY
100
DELISTED
HMS Holdings Corp.
HMSY
| – | – |
-98,300
| Closed | -$3.39M |
|